CareSpan Health Valuation
Is CSPN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CSPN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate CSPN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CSPN's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CSPN?
Key metric: As CSPN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is CSPN's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | US$2.02m |
| Market Cap | US$681.15k |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | -1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CSPN's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.1x | ||
CBP Certive Solutions | 1x | n/a | CA$1.8m |
CHS Comprehensive Healthcare Systems | 0.1x | n/a | CA$620.1k |
EKG CardioComm Solutions | 3x | n/a | CA$1.9m |
HMRK Highmark Interactive | 0.2x | n/a | CA$617.1k |
CSPN CareSpan Health | 0.3x | n/a | CA$952.3k |
Price-To-Sales vs Peers: CSPN is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (1.4x).
Price to Sales Ratio vs Industry
How does CSPN's PS Ratio compare vs other companies in the CA Healthcare Services Industry?
| 7 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 2.2x | 9.8% | |
CSPN CareSpan Health | 0.3x | n/a | US$681.15k |
THNK Think Research | 0.3x | 6.5% | US$17.84m |
CRBK Carebook Technologies | 0.4x | n/a | US$4.41m |
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 2.2x | 31.1% | |
CSPN CareSpan Health | 0.3x | n/a | US$681.15k |
Price-To-Sales vs Industry: CSPN is good value based on its Price-To-Sales Ratio (0.3x) compared to the North American Healthcare Services industry average (2.1x).
Price to Sales Ratio vs Fair Ratio
What is CSPN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CSPN's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
NeuPath Health
CA$9.0m
Provides chronic pain management services in Canada.
NPTH
CA$0.17
7D
6.3%
1Y
9.7%
Medical Facilities
CA$369.6m
Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.
DR
CA$15.55
7D
3.2%
1Y
79.1%
Carebook Technologies
CA$6.2m
Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.
CRBK
CA$0.05
7D
-37.5%
1Y
-28.6%